• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting Trop-2 as a Cancer Driver.

作者信息

Guerra Emanuela, Trerotola Marco, Alberti Saverio

机构信息

Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, Italy.

Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, Italy.

出版信息

J Clin Oncol. 2023 Oct 10;41(29):4688-4692. doi: 10.1200/JCO.23.01207. Epub 2023 Aug 7.

DOI:10.1200/JCO.23.01207
PMID:37549340
Abstract
摘要

相似文献

1
Targeting Trop-2 as a Cancer Driver.将Trop-2作为癌症驱动因子进行靶向治疗。
J Clin Oncol. 2023 Oct 10;41(29):4688-4692. doi: 10.1200/JCO.23.01207. Epub 2023 Aug 7.
2
Targeting Trop-2 in solid tumors: future prospects.靶向实体瘤中的Trop-2：未来前景
Onco Targets Ther. 2019 Mar 1;12:1781-1790. doi: 10.2147/OTT.S162447. eCollection 2019.
3
Upregulation of Trop-2 quantitatively stimulates human cancer growth.Trop-2 的上调定量刺激了人类癌症的生长。
Oncogene. 2013 Jan 10;32(2):222-33. doi: 10.1038/onc.2012.36. Epub 2012 Feb 20.
4
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability.基于 3D 结构信息的 Trop-2 信号激活位点靶向治疗驱动肿瘤选择性杀伤。
Mol Cancer Ther. 2023 Jun 1;22(6):790-804. doi: 10.1158/1535-7163.MCT-22-0352.
5
ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer.免疫 PET 检测胰腺癌中滋养层细胞表面抗原 2（Trop-2）的表达。
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):861-870. doi: 10.1007/s00259-021-05563-1. Epub 2021 Sep 14.
6
TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling.TROP-2 通过双重抑制 IGF-1R 和 ALK 信号通路发挥抑癌作用。
Gynecol Oncol. 2019 Jan;152(1):185-193. doi: 10.1016/j.ygyno.2018.10.039. Epub 2018 Nov 12.
7
Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting.鉴定和表征针对 Trop-2 的特异性纳米抗体用于肿瘤靶向。
Int J Mol Sci. 2022 Jul 19;23(14):7942. doi: 10.3390/ijms23147942.
8
In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.在人输卵管浆液性癌中，针对滋养层细胞表面抗原 2（Trop-2）的抗体药物偶联物 sacituzumab govitecan 的体内外活性。
Gynecol Oncol. 2020 Feb;156(2):430-438. doi: 10.1016/j.ygyno.2019.11.018. Epub 2019 Dec 12.
9
Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer.靶向Trop-2的四聚体兰吡奈酶对三阴性乳腺癌具有强大的抗肿瘤活性。
Mol Cancer. 2014 Mar 10;13:53. doi: 10.1186/1476-4598-13-53.
10
Chemotherapy agents-induced immunoresistance in lung cancer cells could be reversed by trop-2 inhibition in vitro and in vivo by interaction with MAPK signaling pathway.化疗药物诱导的肺癌细胞免疫抗性在体外和体内可通过与丝裂原活化蛋白激酶（MAPK）信号通路相互作用的Trop-2抑制作用而被逆转。
Cancer Biol Ther. 2013 Dec;14(12):1123-32. doi: 10.4161/cbt.26341. Epub 2013 Sep 4.

引用本文的文献

1
The prognostic and therapeutic potential of Claudin-6 and Trop-2 expression as targeted biomarkers in serous ovarian cancer: An observational study.Claudin-6和Trop-2表达作为浆液性卵巢癌靶向生物标志物的预后及治疗潜力：一项观察性研究。
Medicine (Baltimore). 2025 Jun 27;104(26):e43110. doi: 10.1097/MD.0000000000043110.
2
Efficacy and Safety of Antibody-Drug Conjugates for Lung Cancer Therapy: A Systematic Review of Randomized and Non-Randomized Clinical Trials.抗体药物偶联物用于肺癌治疗的疗效和安全性：对随机和非随机临床试验的系统评价
Pharmaceutics. 2025 May 3;17(5):608. doi: 10.3390/pharmaceutics17050608.
3
Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization.
最后的手段？难治性复发/转移性头颈部鳞状细胞癌综合分子分析的原理：一例在分子和功能特征分析后对戈沙妥珠单抗有显著反应的病例报告
Biomedicines. 2025 May 21;13(5):1266. doi: 10.3390/biomedicines13051266.
4
Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution.精准靶向肺癌：抗体药物偶联物治疗变革
Curr Oncol Rep. 2025 Apr 16. doi: 10.1007/s11912-025-01655-5.
5
Large, recursive membrane platforms are associated to Trop-1, Trop-2, and protein kinase signaling for cell growth.大型递归膜平台与Trop-1、Trop-2以及细胞生长的蛋白激酶信号传导相关。
Mol Biol Cell. 2025 Mar 1;36(3):ar38. doi: 10.1091/mbc.E24-06-0267. Epub 2025 Jan 9.
6
Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back.Sacituzumab govitecan 在三阴性乳腺癌中的应用：从基础研究到临床应用，再回到基础研究。
Front Immunol. 2024 Aug 15;15:1447280. doi: 10.3389/fimmu.2024.1447280. eCollection 2024.
7
Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs.靶向Trop-2的抗体偶联药物的进展与创新联合疗法
Pharmaceuticals (Basel). 2024 May 17;17(5):652. doi: 10.3390/ph17050652.